Icon

Oxytrol - (3.9MG/24HR; Film, Extended Release: Transdermal)

Oxybutynin Allergan
3.9MG/24HR; Film, Extended Release: Transdermal
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
Indications for OXYTROL: Overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Yes
**** *** *** ***** ** **** **** ** **** ***** ******* *******-*** **,**** ; *******-*** **,**** ; *******-*** **,**** ; *******-*** **,**** ; *******-*** **,**** ; *******-*** **,**** ; *******-*** **,**** ; *******-*** **,****. ************ **** *** ********* ******* ****** ***** * **** ******* **** ********* ** *** ***** ** ***** **** ******** *** ******* ** **** ****. ***** ** ** ***** **** ** *** *** ***** ******* *** **** ******* ******** ***** ** *** *** *****. ***** ****** *** ******** ** ****.
Oxytrol Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
**** (****) ******* ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** (****) *** \ ** *** **. **** ******* ******** ************ *********
  1. *** **, **** : **** (****) ******** ****** **** ***** *** **** ** ****** *** ******* '***, '***, ' ***, '***, ***, '***, ' ***, '***.
  2. *** **, **** : ****** **** **** **** *** **** ** ****** ** ******** ***** ** ********.
  3. *** **, **** : ****** *** **** (**** )******* ** ** **********. ***** ***** ** *** ********** *********, ****** *** ******* **** * *******-******* ******* ** *** *.*. ******* ******** ******* ** ******** ********* * ******* ********** ******* ** ***** **, ****, ** ******* ** ******* *************.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.